Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2013 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00067054
First received: August 8, 2003
Last updated: July 18, 2014
Last verified: September 2013
  Purpose

This study collects specimens from volunteers for use in studies by NIAID's Vaccine Research Center. A number of different types of specimens or samples can be collected, including blood, urine, body fluids or secretions, skin swabs, or skin biopsies. The samples are used for medical research, including the study of HIV, hepatitis, and other diseases; immune system responses, such as responses to vaccinations or infections; and for research on vaccine development.

Blood samples may be collected either by ordinary blood drawing (phlebotomy) or by apheresis, a procedure for collecting a larger quantity of blood cells or plasma than would be possible through simple blood drawing. For this procedure, the subject lies on a recliner or couch. Blood is removed through a needle in the vein of one arm and spun in a machine that separates out the desired component (plasma or white blood cells). The remainder of the blood is returned either through the same needle or through a needle in the other arm. The procedure takes about 1 to 3 hours.

Volunteers who are 18 years of age and older, including participants in other NIH research protocols, may be eligible. Individuals who have a condition that the research staff considers a reason not to make a sample donation will be excluded from the study.

Participants may have only one sample collected or may be asked to undergo repetitive sample collection procedures, depending upon the requirements of the particular research project for which the samples are being collected. Each individual's enrollment is for a 1-year period, which can be extended.


Condition
Blood Component Removal

Study Type: Observational
Official Title: Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 3000
Study Start Date: August 2003
Detailed Description:

Protocol Design: This protocol is designed to perform collection of human specimens, such as blood, mucosal secretions, skin swabs, skin biopsy, or body fluids to support research studies. These samples will be used by laboratory researches in their work on the development of vaccines for HIV and other infectious diseases, to study the correlates of immunity related to infectious diseases and in laboratory work related to the development and/or validation of immunological assays.

In order to carry out research studies, it is often necessary to obtain larger quantities of plasma or mononuclea cells than can be safely obtained by simple phlebotomy. These components can be safely obtained using apheresis procedures in the Apheresis Clinic of the Clinical Center Department of Transfusion Medicine (DTM). The aphereses performed through this protocol conform to the requirements of the DTM Apheresis Clinic.

Subjects: Volunteers, at least 18 years old, (including participants in other NIH research studies) who agree to donate specimens for research purposes.

Protocol Plan: Subjects will receive information about study procedures and, if willing to participate, will sign the informed consent. The informed consent can be used for as long as one year. If there is an ongoing willingness to donate samples the subject must sign a new consent and have eligibility confirmed at least once per year.

Duration: Individual subjects may donate samples as often as permitted by the protocol. The protocol will undergo continuing review by the IRB annually and remain open if approved and there continues to be a need for plasma or PBMC samples obtained by apheresis or other types of specimens in support of research studies.

Endpoints: This protocol does not have an analysis plan but rather will be conducted in accordance with Good Clinical Practices for human research solely for the purpose of obtaining samples for research laboratories. Samples will be identified only by protocol identification number. Subject data, such as demographic information, aspects of medical history, laboratory parameters, recent immunizations or medications, HLA type, genetic tests and other medical information may be provided (identified by study number, but not subject name) to researchers if needed to support the objectives of the laboratory research.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:

A volunteer must meet all of the inclusion criteria, as follows:

  1. Age 18 years or older.
  2. Able to provide informed consent.
  3. Willing to provide blood or other samples to be stored for future research.
  4. Able to provide proof of identity to the acceptance of the clinician completing the enrollment process: when the telephone consent process is used a clinician who will be performing the sample collection will review the proof of identity.

EXCLUSION CRITERIA:

Any medical condition that the attending physician considers a contraindication to the specimen collection procedures that the volunteer will be asked to undergo.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00067054

Contacts
Contact: Ingelise Gordon, R.N. (301) 451-8715 vaccines@nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)    800-411-1222 ext TTY8664111010    prpl@mail.cc.nih.gov   
Sponsors and Collaborators
Investigators
Principal Investigator: Julie E Ledgerwood, D.O. National Institute of Allergy and Infectious Diseases (NIAID)
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00067054     History of Changes
Other Study ID Numbers: 030263, 03-I-0263
Study First Received: August 8, 2003
Last Updated: July 18, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Volunteer
Plasmapheresis
Leukapheresis
Immunology
Leukocyte
Healthy Volunteer
HV

ClinicalTrials.gov processed this record on July 20, 2014